Notes

Review Studies Diversity Structures Structures
Quantitative studies of goat milk oligosaccharides range from to 3 mgL in mature milk and from 0 to 6 mgL in colostrum. These levels are clearly lower than in human milk and potential functionalities of gMOS. Some studies have shown anti-inflammatory effects of mixtures enriched in gMOS. Goat MOS also display prebiotic potential, particularly in stimulating growth of bifidobacteria preferentially. Although Purchase of gMOS are still limited, several structures are also found in human milk and have known functions as immune modulators and pathogen inhibitors. In conclusion, goat milk constitutes a promising alternative source for milk oligosaccharides, which can be used in infant formula.

Conflict of interest statement The authors declare the following competing financial interest(s) Eric Benjamins and Alfred Haandrikman are employed by Ausnutria BV. Evelien M. te Poele, Anastasia Chrysovalantou Chatziioannou, and Lubbert Dijkhuizen are employed by CarbExplore Research BV, which has received financial support from Ausnutria BV, at least partly used to fund the work of Associations between human milk oligosaccharides and growth in infancy and early Lagström H(1)(2), Rautava S(3), Ollila H(1), Kaljonen A(4), Turta O(3), Mäkelä Center of Research Excellence (MOMI CORE), University of California San Diego, BACKGROUND Breastfeeding modulates infant growth and protects against the development of obesity. However, whether or not maternal variation in human milk components, such as human milk oligosaccharides (HMOs), is associated with programming of child growth remains unknown.OBJECTIVE Our objective was to determine the association between maternal HMO composition and child growth during the first 5 y of life. In addition, the association between maternal prepregnancy BMI and HMO composition was assessed.METHODS Human milk samples from 2 mothers were obtained from a prospective population-based birth cohort study, Steps to healthy development of Children analyzed by HPLC.

Child growth data from 3 mo to 5 y were collected from municipal well-baby clinics and linked to maternal HMO composition data to test RESULTS Maternal HMO composition 3 mo after delivery was associated with height and weight during the first 5 y of life in children of secretor mothers. Specifically, HMO diversity and the concentration of lacto-N-neo-tetraose (LNnT) were inversely associated and that of 2'-fucosyllactose (2'FL) was directly associated with child height and weight z scores in a model adjusted for maternal prepregnancy BMI, mode of delivery, birthweight z score, sex, and time. Maternal prepregnancy BMI was associated with HMO composition.CONCLUSIONS The association between maternal HMO composition and childhood growth may imply a causal relation, which warrants additional testing in preclinical and clinical studies, especially since 2'FL and LNnT are among the HMOs now being added to infant formula. Furthermore, altered HMO composition may mediate the impact of maternal prepregnancy BMI on childhood obesity, which warrants further investigation to establish the cause-and-effect relation.Profiles of human milk oligosaccharides and production of some human milk oligosaccharides in transgenic animals.During the decade of the 19s and the first years of the current century, our group embarked on a project to study and synthesize human milk oligosaccharides.

This report describes 2 unexpected collateral observations from that endeavor. Seebio 2'-fucosyllactose was the detection and confirmation of 2 rare neutral human milk oligosaccharides profiles that were uncovered while assessing oligosaccharide content in hundreds of samples of human milk. One of these lacked fucosylated structures altogether, and the other lacked the oligosaccharide 3-fucosyllactose [Galβ1-4(Fucα1-3)Glc]. We used glycoconjugate probes to determine whether the unusual profiles were mirrored by fucosylation of milk glycoproteins. The results show that the lack of fucosylated oligosaccharides in these samples corresponds to the absence of equivalent fucosylated motifs in milk glycoproteins. The second finding was a shortened and distinct lactation process in transgenic rabbits expressing the human fucosyltransferase 1. During the first day of lactation, these animals expressed milk that contained both lactose and 2'-fucosylactose, but on the second day, the production of milk was severely diminished, and by the fourth day, no lactose was detected in their milk.

Meanwhile, the concentration of fucosylated glycoproteins increased from the onset of lactation through its premature termination.
Read More: https://en.wikipedia.org/wiki/2%27-Fucosyllactose